264 related articles for article (PubMed ID: 31123587)
1. Erythrocytic α-Synuclein as a potential biomarker for Parkinson's disease.
Tian C; Liu G; Gao L; Soltys D; Pan C; Stewart T; Shi M; Xie Z; Liu N; Feng T; Zhang J
Transl Neurodegener; 2019; 8():15. PubMed ID: 31123587
[TBL] [Abstract][Full Text] [Related]
2. Erythrocytic alpha-synuclein as potential biomarker for the differentiation between essential tremor and Parkinson's disease.
Yu Z; Liu G; Zheng Y; Huang G; Feng T
Front Neurol; 2023; 14():1173074. PubMed ID: 37693770
[TBL] [Abstract][Full Text] [Related]
3. Oral Mucosa Derived α-Synuclein as a Potential Diagnostic Biomarker for Parkinson's Disease.
Zheng Y; Yu Z; Zhao J; Cai H; Wang Z; Wang X; Feng T
Front Aging Neurosci; 2022; 14():867528. PubMed ID: 35418851
[TBL] [Abstract][Full Text] [Related]
4. Erythrocytic α-Synuclein Species for Parkinson's Disease Diagnosis and the Correlations With Clinical Characteristics.
Yu Z; Liu G; Li Y; Arkin E; Zheng Y; Feng T
Front Aging Neurosci; 2022; 14():827493. PubMed ID: 35185529
[TBL] [Abstract][Full Text] [Related]
5. Investigation of α-Synuclein Species in Plasma Exosomes and the Oligomeric and Phosphorylated α-Synuclein as Potential Peripheral Biomarker of Parkinson's Disease.
Zheng H; Xie Z; Zhang X; Mao J; Wang M; Wei S; Fu Y; Zheng H; He Y; Chen H; Xu Y
Neuroscience; 2021 Aug; 469():79-90. PubMed ID: 34186110
[TBL] [Abstract][Full Text] [Related]
6. Phosphorylated α-synuclein in diluted human serum as a biomarker for Parkinson's disease.
Chen WR; Chen JC; Chang SY; Chao CT; Wu YR; Chen CM; Chou C
Biomed J; 2022 Dec; 45(6):914-922. PubMed ID: 34974168
[TBL] [Abstract][Full Text] [Related]
7. A Comparative Study of the Diagnostic Potential of Plasma and Erythrocytic α-Synuclein in Parkinson's Disease.
Wang L; Wang G; Duan Y; Wang F; Lin S; Zhang F; Li H; Li A; Li H
Neurodegener Dis; 2019; 19(5-6):204-210. PubMed ID: 32485710
[TBL] [Abstract][Full Text] [Related]
8. Alpha-Synuclein species in oral mucosa as potential biomarkers for multiple system atrophy.
Zheng Y; Cai H; Zhao J; Yu Z; Feng T
Front Aging Neurosci; 2022; 14():1010064. PubMed ID: 36304930
[TBL] [Abstract][Full Text] [Related]
9. Plasma and serum alpha-synuclein as a biomarker in Parkinson's disease: A meta-analysis.
Zubelzu M; Morera-Herreras T; Irastorza G; Gómez-Esteban JC; Murueta-Goyena A
Parkinsonism Relat Disord; 2022 Jun; 99():107-115. PubMed ID: 35717321
[TBL] [Abstract][Full Text] [Related]
10. α-Synuclein in salivary extracellular vesicles as a potential biomarker of Parkinson's disease.
Cao Z; Wu Y; Liu G; Jiang Y; Wang X; Wang Z; Feng T
Neurosci Lett; 2019 Mar; 696():114-120. PubMed ID: 30579996
[TBL] [Abstract][Full Text] [Related]
11. Erythrocytic alpha-synuclein in early Parkinson's disease: A 3-year longitudinal study.
Liu G; Yu Z; Gao L; Zheng Y; Feng T
Parkinsonism Relat Disord; 2022 Nov; 104():44-48. PubMed ID: 36228514
[TBL] [Abstract][Full Text] [Related]
12. Alterations of Erythrocytic Phosphorylated Alpha-Synuclein in Different Subtypes and Stages of Parkinson's Disease.
Li XY; Li W; Li X; Li XR; Sun L; Yang W; Cai Y; Chen Z; Wu J; Wang C; Yu S
Front Aging Neurosci; 2021; 13():623977. PubMed ID: 34658833
[TBL] [Abstract][Full Text] [Related]
13. Heterogeneity in α-synuclein subtypes and their expression in cortical brain tissue lysates from Lewy body diseases and Alzheimer's disease.
Vaikath NN; Erskine D; Morris CM; Majbour NK; Vekrellis K; Li JY; El-Agnaf OMA
Neuropathol Appl Neurobiol; 2019 Oct; 45(6):597-608. PubMed ID: 30422353
[TBL] [Abstract][Full Text] [Related]
14. Phosphorylated α-synuclein can be detected in blood plasma and is potentially a useful biomarker for Parkinson's disease.
Foulds PG; Mitchell JD; Parker A; Turner R; Green G; Diggle P; Hasegawa M; Taylor M; Mann D; Allsop D
FASEB J; 2011 Dec; 25(12):4127-37. PubMed ID: 21865317
[TBL] [Abstract][Full Text] [Related]
15. Oligomeric and phosphorylated alpha-synuclein as potential CSF biomarkers for Parkinson's disease.
Majbour NK; Vaikath NN; van Dijk KD; Ardah MT; Varghese S; Vesterager LB; Montezinho LP; Poole S; Safieh-Garabedian B; Tokuda T; Teunissen CE; Berendse HW; van de Berg WD; El-Agnaf OM
Mol Neurodegener; 2016 Jan; 11():7. PubMed ID: 26782965
[TBL] [Abstract][Full Text] [Related]
16. Plasma pS129-α-Synuclein Is a Surrogate Biofluid Marker of Motor Severity and Progression in Parkinson's Disease.
Lin CH; Liu HC; Yang SY; Yang KC; Wu CC; Chiu MJ
J Clin Med; 2019 Oct; 8(10):. PubMed ID: 31623323
[TBL] [Abstract][Full Text] [Related]
17. A longitudinal study on α-synuclein in plasma neuronal exosomes as a biomarker for Parkinson's disease development and progression.
Niu M; Li Y; Li G; Zhou L; Luo N; Yao M; Kang W; Liu J
Eur J Neurol; 2020 Jun; 27(6):967-974. PubMed ID: 32150777
[TBL] [Abstract][Full Text] [Related]
18. Is peripheral alpha synuclein a marker for gait velocity in Parkinson's disease?
Chatterjee K; Choudhury S; Banerjee R; Siddique U; Sarkar S; Roy A; Chatterjee CS; Ghosal A; Basu P; Kumar H
Neurosci Lett; 2022 Aug; 786():136819. PubMed ID: 35905887
[TBL] [Abstract][Full Text] [Related]
19. Detection and Assessment of α-Synuclein Oligomers in the Urine of Parkinson's Disease Patients.
Nam D; Lee JY; Lee M; Kim J; Seol W; Son I; Ho DH
J Parkinsons Dis; 2020; 10(3):981-991. PubMed ID: 32444560
[TBL] [Abstract][Full Text] [Related]
20. Salivary alpha-synuclein as a biomarker for Parkinson's disease: a systematic review.
Bougea A; Koros C; Stefanis L
J Neural Transm (Vienna); 2019 Nov; 126(11):1373-1382. PubMed ID: 31401695
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
